These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 6984078)

  • 1. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
    Soltis RD; Hasz DE
    J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.
    Casali P; Lambert PH
    Clin Exp Immunol; 1979 Aug; 37(2):295-309. PubMed ID: 498587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
    Veerhuis R; van Es LA; Daha MR
    Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of virus and antibody containing immune complexes from mink with Aleutian disease by affinity chromatography of equine complement clq.
    Burger D; Sriranganathan N; McDonald TL; Gorham JR
    Am J Vet Res; 1983 Jan; 44(1):86-90. PubMed ID: 6297342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P; Michaelsen TE; Aase A; Mollnes TE
    J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific detection of soluble immune complexes in conglutinin-binding assays.
    D'Amelio R; Brighouse G; Barnet M; Lambert PH
    Clin Exp Immunol; 1981 Aug; 45(2):283-9. PubMed ID: 7318255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of soluble aggregates of IgG on the binding, uptake and degradation of the C1q subcomponent of complement by adherent guinea pig peritoneal macrophages.
    Veerhuis R; Van Es LA; Daha MR
    Eur J Immunol; 1985 Sep; 15(9):881-7. PubMed ID: 3876223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radioimmunoassay for human antigen-antibody complexes in clinical material.
    Cowdery JS; Treadwell PE; Fritz RB
    J Immunol; 1975 Jan; 114(1 Pt 1):5-9. PubMed ID: 1167561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
    Shepherd PS
    Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specific in vitro antibody-mediated retention of bovine serum albumin by porcine hyaline articular cartilage.
    Aston WP; Ward TL; Cooke TD
    Clin Exp Immunol; 1983 May; 52(2):280-6. PubMed ID: 6861375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
    Caillot G; Lamelin JP; Hartmann DJ; Ville G
    Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.